ダウンロード数: 247
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
24_0535.pdf | 338.27 kB | Adobe PDF | 見る/開く |
タイトル: | 奈良医大泌尿器科における進行膀胱癌の治療成績 |
その他のタイトル: | IMMUNO-CHEMOTHERAPY FOR ADVANCED CANCER OF THE URINARY BLADDER IN THE DEPARTMENT OF UROLOGY, NARA MEDICAL UNIVERSITY |
著者: | 平松, 侃 本宮, 義恢 馬場谷, 勝廣 岡島, 英五郎 |
著者名の別形: | Hiramatsu, Tadashi Motomiya, Yoshihiro Babaya, Katsuhiro Okajima, Eigoro |
発行日: | Jul-1978 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 24 |
号: | 7 |
開始ページ: | 535 |
終了ページ: | 539 |
抄録: | Since 1962, 35 cases of advanced cancer of the urinary bladder were treated with immuno-chemotherapy. The patients in whom this therapy was discontinued because of marked side effects were excluded from this report. Single or combined administration with chromomycin A3, cyclophosphamide, mitomycin C, 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil, adriamycin and OK-432 were examined. Intravenous, intraarterial, oral and transrectal administration were performed, otherwise cases given intracavitary were excluded from this report. According to the criteria by Karnofsky, 35 cases were classified as follows 17 cases of 0-0, 6 cases of 0-A, 5 cases of 0-B, 4 cases of 0-C and 3 cases of 1-A. Cases of combined administration with mitomycin C, 1-(2-tetrahydrofuryl)-5-fluorouracil, adriamycin and OK-432 showed relatively effective results. |
URI: | http://hdl.handle.net/2433/122239 |
出現コレクション: | Vol.24 No.7 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。